Patent details

EP3616695 Title: CEFTOLOZANE/TAZOBACTAM FOR TREATING INTRAPULMONARY INFECTIONS

Basic Information

Publication number:
EP3616695
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP192036168
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CEFTOLOZANE/TAZOBACTAM FOR TREATING INTRAPULMONARY INFECTIONS
French Title of Invention:
CEFTOLOZANE/TAZOBACTAM POUR LE TRAITEMENT DES INFECTIONS INTRAPULMONAIRES
German Title of Invention:
CEFTOLOZAN/TAZOBACTAM ZUR BEHANDLUNG INTRAPULMONALER INFEKTIONEN
SPC Number:

Dates

Filing date:
07/09/2012
Grant date:
23/10/2024
EP Publication Date:
04/03/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/10/2024
EP B1 Publication Date:
23/10/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
07/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/10/2024
 
 

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue, Rahway, New Jersey 07065, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
31/10/2024
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
UMEH, Obiamiwe, C.
Address:
United States (US)

2

Name:
PARSONS, Tara
Address:
United States (US)

3

Name:
CHANDORKAR, Gurudatt, A.
Address:
United States (US)

4

Name:
HUNTINGTON, Jennifer, A.
Address:
United States (US)

Priority

1

Priority Number:
201161532914 P
Priority Date:
09/09/2011
Priority Country:
United States (US)

2

Priority Number:
201261657386 P
Priority Date:
08/06/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/397; A61K 9/00; A61K 31/431; A61K 31/546; A61P 31/04;

Publication

European Patent Bulletin

Issue number:
202443
Publication date:
23/10/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/08/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
05/11/2024 Outgoing Correspondence 1
31/10/2024 Power Of Attorney 1